Clinical Trial

A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF AKR-001 IN SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

Study Status:

Contact Information:

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose

The purpose of this study is to evaluate the safety and efficacy of AKR-001 in subjects with NASH.

Information

Principal Investigator Rama Behara, MD
Co-PI
Sponsor
Type of Trial Prospective/Interventional